Evogene Revenue

In the year 2024, Evogene had annual revenue of $8.51M USD with 50.90% growth. Evogene had revenue of $1.61M in the quarter ending December 31, 2024, with 178.72% growth.

Revenue

$8.51M

Revenue Growth

+50.90%

P/S Ratio

0.86

Revenue / Employee

$72.74K

Employees

117

Market Cap

26.81M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.51M	2.87M	50.90%
Dec 31, 2023	5.64M	3.97M	236.72%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%
Dec 31, 2020	1.04M	287.00K	38.11%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Teva Pharmaceutical Industries	61.87B
Danel (Adir Yeoshua)	2.77B
Kamada	586.24M
Bait Bakfar	103.40M
Novolog (Pharm-Up 1966)	2.02B
SofWave Medical	235.09M
Ilex Medical	920.37M
BrainsWay	149.39M

Revenue Rankings

Evogene News

5 days ago - Evogene Schedules First Quarter 2025 Financial Results Release - PRNewsWire
22 days ago - ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - PRNewsWire
2 months ago - Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript - Seeking Alpha
2 months ago - Evogene GAAP EPS of -$0.06 beats by $0.66, revenue of $1.61M misses by $2.02M - Seeking Alpha
2 months ago - Evogene appoints Nir Nimrodi as new chair - Seeking Alpha
2 months ago - Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
2 months ago - Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - PRNewsWire
2 months ago - Earnings Scheduled For March 6, 2025 - Benzinga

More News